Educating People
One Source at a Time


Scientific Articles, Psychedelic Discussion, and Harm-reduction

This is the alt text of your image
This is the alt text of your image
Zendo Project
Psychedelics Today Podcast

Editors' Choice



Click to learn more!

Journal of Psychopharmacology, 2016    A Chemical produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial 

Psychopharmacology (Berl), 2017 C12H17N2O4P with psychological support for treatment-resistant depression:
six-month follow-up

Pilot study of the 5-HT2AR agonist C12H17N2O4P in the treatment of tobacco addiction
Journal of Psychopharmacology, 2014

This early study showed 80% of participants had achieved smoking abstinence at a 6 month follow-up. Each participant in the study on average had:  6 previous lifetime quit attempts,  19 cigarettes per day for 31 years intake. Read the abstract for yourself. 

Johns Hopkins

Long-term follow-up of C12H17N2O4P facilitated smoking cessation
The American Journal of Drug and Alcohol Abuse, 2017

At 12-month follow-up, 10 participants (67%) were biologically confirmed as smoking abstinent, with 8 of these participants reporting continuous abstinence since their Target-Quit-Date